UBS has downgraded Swedish mining-equipment maker Epiroc AB to sell from neutral, while simultaneously lifting its 12-month price target to SKr230 from SKr200. The broker said the company's 32% rally so far this year has pushed valuation levels to a point that is difficult to justify against the underlying business outlook.
The stock reaction was immediate: shares were down 4.6% as of 06:32 ET (10:32 GMT). Epiroc closed at SKr277 on June 22, which UBS said implies roughly 17% downside to the bank's revised target.
Market positioning and valuation
UBS noted that Epiroc has outpaced its mining equipment peers by around 18 percentage points year-to-date. That outperformance, the bank argues, has eroded what it describes as a "quality premium" and driven the stock to trade at a forward EV/EBIT multiple of 22.4x - about 17% higher than the company's five-year average.
Using a reverse discounted cash flow framework, UBS estimated that the current share price embeds assumptions of approximately 15% revenue growth and a 40% drop-through on incremental revenue over the 2027-2029 period. The bank contrasted these implicit assumptions with its through-cycle view of roughly 5.5% organic growth.
Those market-implied forecasts would translate to an adjusted EBIT margin near 25% by 2029, a level above the historical peak margin of 23.7% recorded in 2021-22 - an outcome UBS considers unlikely.
Operational performance versus sustainability questions
UBS acknowledged Epiroc's strong first-quarter 2026 trading, pointing out that equipment orders rose 44% organically. However, the bank emphasized that recent margin gains have been driven primarily by two factors: higher production volumes that improve absorption of fixed overheads, and a favourable Equipment-to-Service revenue mix. UBS flagged both elements as potentially temporary, questioning the sustainability of margin expansion if those drivers reverse.
Four specific earnings risks highlighted by UBS
- Consensus margin expectations look ambitious - street forecasts see equipment and services margins at 23.7% in fiscal 2026 and 24.3% in fiscal 2027, while UBS models a more cautious 23.6% only by 2028.
- Consensus projects roughly 34% organic equipment order growth in Q2 2026, a level UBS says is high given that no large orders had been announced in the quarter to date.
- Equipment book-to-bill only turned positive in Q1 2026; historically this metric correlates with organic revenue growth about four quarters later, implying UBS expects just 1%-2% equipment revenue growth for the rest of 2026.
- An anticipated copper-driven acceleration versus peer Sandvik may not occur, because Sandvik faces easier comparables in that commodity.
Earnings forecasts and valuation scenarios
UBS left its 2026 earnings estimates unchanged, while nudging its 2027 forecasts up by 3% and 2028 by 5%. Even with those upgrades, the broker's adjusted EBIT estimates sit below consensus by 5% for 2026, 7% for 2027 and 3% for 2028.
For investors weighing outcomes, UBS set out scenario-based valuations. In an upside case the stock could be worth SKr300 per share, anchored to average revenue growth of 20% and a 40% drop-through between 2027 and 2029. In a downside case, assuming no revenue growth over the same period, the bank values the company at SKr170 per share.
Bottom line
UBS's move reflects a tension between recent strong order momentum and what the broker judges to be aggressive market expectations reflected in current prices. The bank has shifted to a sell recommendation while raising its price target, highlighting valuation as the central concern and listing several demand and margin-related risks that could keep consensus forecasts under pressure.
Shares remain sensitive to incoming order announcements, the sustainability of margin drivers, and near-term equipment revenues, factors UBS says will determine whether the recent rerating is justified or needs to reverse.